RT Journal Article
SR Electronic
T1 Age-severity matched cytokine profiling reveals specific signatures in Covid-19 patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.28.20162735
DO 10.1101/2020.07.28.20162735
A1 Angioni, Roberta
A1 Sanchez-Rodriguez, Ricardo
A1 Munari, Fabio
A1 Bertoldi, Nicole
A1 Arcidiacono, Diletta
A1 Cavinato, Silvia
A1 Marturano, Davide
A1 Cattelan, Annamaria
A1 Viola, Antonella
A1 Molon, Barbara
YR 2020
UL http://medrxiv.org/content/early/2020/07/29/2020.07.28.20162735.abstract
AB A global effort is currently undertaken to restrain the COVID-19 pandemic. Host immunity has come out as a determinant for COVID-19 clinical outcome, and several studies investigated the immune profiling of SARS-CoV-2 infected people to properly direct the clinical management of the disease. Thus, lymphopenia, T-cell exhaustion, and the increased levels of inflammatory mediators have been described in COVID-19 patients, in particular in severe cases1. Age represents a key factor in COVID-19 morbidity and mortality2. Understanding age-associated immune signatures of patients is therefore important to identify preventive and therapeutic strategies. In this study, we investigated the immune profile of COVID-19 hospitalized patients identifying a distinctive age-dependent immune signature associated with disease severity. Indeed, defined circulating factors - CXCL8, IL-10, IL-15, IL-27 and TNF-α - positively correlate with older age, longer hospitalization, and a more severe form of the disease and may thus represent the leading signature in critical COVID-19 patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was funded by Fondazione Citta della Speranza, grant number 20/02CoV, to AV.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was approved by the Ethics Committee for Clinical Research of Padova (GS-US-540-5774). The study was performed according to the ethical guidelines of the Declaration of Helsinki (7th revision). All the patients gave their written informed consent and all analyses were carried out on anonymised data as required by the Italian Data Protection Code (Legislative Decree 196/2003) and the general authorization issued by the Data Protection Authority.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data supporting the findings of this study are available from the corresponding authors upon written request.